This inventor holds 1 USPTO granted patent. Top assignee: University of South Florida. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations of Sami Abdulkadir in Angiogenesis Modulation
Introduction
Sami Abdulkadir is an accomplished inventor based in Tampa, FL (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of angiogenesis. His work focuses on developing novel therapeutic approaches that can impact various medical conditions.
Latest Patents
Sami Abdulkadir holds a patent titled "Modulating angiogenesis by proteomimetics of vascular endothelial growth factor." This patent presents innovative VEGF mimics, pharmaceutical compositions, and methods for their use in either increasing or reducing angiogenesis. His research has the potential to lead to new treatments for diseases where angiogenesis plays a critical role.
Career Highlights
Sami Abdulkadir is affiliated with the University of South Florida, where he conducts his research and development activities. His academic background and expertise in the field have positioned him as a key figure in angiogenesis research.
Collaborations
One of his notable collaborators is Jianfeng Cai, with whom he has worked on various projects related to his patent and research initiatives.
Conclusion
Sami Abdulkadir's innovative work in angiogenesis modulation showcases the potential of his research to contribute to advancements in medical therapies. His patent and collaborations highlight his commitment to improving health outcomes through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile